Erythromycin Prophylaxis for Neonatal Conjunctivitis: Ointment Versus Drops

Isr Med Assoc J. 2016 Jul;18(7):404-406.

Abstract

Background: Due to a shortage of individualized erythromycin ointment (IEO), we switched to shared erythromycin drops (SED). Following this change, nurses claimed observing more cases of eye discharge.

Objectives: To test whether switching from IEO to SED affected the rate of neonatal conjunctivitis (NC).

Methods: The study group included 14,916 neonates > 35 weeks of gestation, further divided into two birth periods of 12 months each: 1 January 2013 to 31 December 2013 (IEO) and 1 February 2014 to 31 January 2015 (SED). We compared the two birth periods with regard to three variables: clinical NC (number of conjunctival swabs/1000 neonates), bacterial NC (number of culture-positive swabs/1000 neonates), and bacterial growth percentage (number of culture-positive swabs/100 samples).

Results: Compared to 2012-2013, the period 2014-2015 included fewer cesarean deliveries and shorter length of stay (LOS). Clinical NC, bacterial NC and bacterial-growth percentage were not different between the two periods. Variables that were independently significantly associated with increased clinical NC included male gender (OR 1.48, CI 1.21-1.81) and LOS (OR 1.24, CI 1.18-1.29). LOS was associated with bacterial NC (OR 1.19, CI 1.11-1.28). Coagulase-negative staphylococci, Escherichia coli and Pseudomonas aeruginosa were the prevalent pathogens, though without difference between periods.

Conclusions: Rates of clinical NC, bacterial NC and bacterial-growth percentage were not different between the study periods. Switching from IEO to SED had no effect on the NC rate.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Cesarean Section / statistics & numerical data*
  • Erythromycin / administration & dosage*
  • Female
  • Humans
  • Infant, Newborn
  • Length of Stay
  • Male
  • Ointments
  • Ophthalmia Neonatorum / epidemiology
  • Ophthalmia Neonatorum / microbiology
  • Ophthalmia Neonatorum / prevention & control*
  • Ophthalmic Solutions
  • Pregnancy
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Bacterial Agents
  • Ointments
  • Ophthalmic Solutions
  • Erythromycin